drugset / Trial / NCT01420666

Maxi-Analgesic Osteoarthritis (OA) Study

NCT01420666

Phase 3 Withdrawn AFT Pharmaceuticals, Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether the analgesic effects of Maxigesic USA are greater than acetaminophen, ibuprofen or placebo in patients who have painful osteoarthritis of the hip or knee.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 325 mg Oral
Comparator Ibuprofen Small molecule 97.5 mg Oral

Indications